Topics and Expertise: funding

Giacomini to lead largest study of genetic, ethnic differences in effectiveness of leading diabetes drug

In people with type 2 diabetes, the body is less able to use the hormone insulin to regulate blood sugar. The disease affects 350 million patients globally—including 29 million in the United States, where it is the leading cause of blindness, kidney failure, and non-accident-related amputations.

Reflection: 30 years of top NIH funding for UCSF School of Pharmacy

Table of contents

Introduction
Budget significance
Reasons for past success
A decade of funding for bioinformatics
New drug discovery directions attract support
Research stalwarts draw funding for decades
New directions in translational research attract support
Expansion of the School’s...

School #1 in NIH funding, 26th year

For the 26th consecutive year, the UCSF School of Pharmacy ranks first among US pharmacy schools in contract and grant funding from the National Institutes of Health (NIH), according to figures for fiscal year 2005.

Ban voted on tobacco industry funds

UCSF faculty members voted last December 52% to 48% to no longer accept funds from manufacturers of tobacco products or their subsidiaries. Those in favor of the ban argued that UCSF must oppose tobacco industry funding of academia since the health sciences campus is a leader in tobacco control...